Author

R. J. Shattock

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 3 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Research Focus:host-pathogen & immune response· 3 Organism:mouse· 3 Assay:proteomics· 2 Research Focus:drug response / drug discovery· 1 Organism:human· 1

Frequent Co-Authors

P. F. McKay· 4 shared A. K. Blakney· 2 shared K. Hu· 2 shared K. Samnuan· 2 shared A. Ensser· 1 shared A. J. Spencer· 1 shared A. Kurshan· 1 shared A. S. Peter· 1 shared

Activity by Year

2020-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 23 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersImmunology

P. F. McKay

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Omicron breakthrough infections in vaccinated or previously infected hamsters

J. Zhou, K. Sukhova, P. F. McKay, A. Kurshan, Y. Yau, T. Lechmere, J. C. Brown, M. Moshe, R. Kugathasan, L. B. Snell, J. D. Edgeworth, R. J. Shattock, K. J. Doores, T. P. Peacock, W. S. Barclay

This study shows Delta and Omicron SARS-CoV-2 variants do not provide cross-protective immunity against reinfection in hamsters.

bioRxiv · May 20, 2022Microbiology

A pair of non-competing neutralizing human monoclonal antibodies protecting from disease in a SARS-CoV-2 infection model

A. S. Peter, E. Roth, S. R. Schulz, K. Fraedrich, T. Steinmetz, D. Damm, M. Hauke, E. Richel, S. Mueller-Schmucker, K. Habenicht, V. Eberlein, L. Issmail, N. Uhlig, S. Dolles, E. Gruner, , H.-M. Jack

The paper identifies two clusters of non-competing neutralizing antibodies against SARS-CoV-2 that protect mice from infection and weight loss.

bioRxiv · Apr 16, 2021 · PreprintImmunology

Heterologous vaccination regimens with self-amplifying RNA and Adenoviral COVID vaccines induce robust immune responses in mice

A. J. Spencer, P. F. McKay, S. Belij-Rammerstorfer, M. Ulaszewska, C. D. Bissett, K. Hu, K. Samnuan, A. K. Blakney, H. R. Sharpe, D. Wright, C. Gilbride, A. Truby, E. R. Allen, S. C. Gilbert, R. J. Shattock, T. Lambe

This study shows that heterologous vaccination with self-amplifying RNA and adenoviral SARS-CoV-2 vaccines in mice produces stronger antibody and cellular immune responses than single-dose regimens.

bioRxiv · Jan 28, 2021Immunology

Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine induces equivalent preclinical antibody titers and viral neutralization to recovered COVID-19 patients

P. F. McKay, K. Hu, A. K. Blakney, K. Samnuan, C. R. Bouton, P. Rogers, K. Polra, P. J. C. Lin, C. Barbosa, Y. Tam, R. J. Shattock

bioRxiv · Apr 22, 2020 · PreprintImmunology